BSE Prices delayed by 5 minutes... << Prices as on May 07, 2024 - 10:48AM >>   ABB  6884.3 ATS - Market Arrow  [-0.84]  ACC  2483.75 ATS - Market Arrow  [-0.28]  AMBUJA CEM  602.7 ATS - Market Arrow  [-0.54]  ASIAN PAINTS  2937.2 ATS - Market Arrow  [0.17]  AXIS BANK  1130.25 ATS - Market Arrow  [-1.21]  BAJAJ AUTO  8939.25 ATS - Market Arrow  [-1.21]  BANKOFBARODA  263 ATS - Market Arrow  [-1.03]  BHARTI AIRTE  1276.5 ATS - Market Arrow  [-0.53]  BHEL  285.2 ATS - Market Arrow  [-1.31]  BPCL  612.5 ATS - Market Arrow  [0.40]  BRITANIAINDS  5196.25 ATS - Market Arrow  [2.66]  CIPLA  1402.55 ATS - Market Arrow  [-1.46]  COAL INDIA  461.7 ATS - Market Arrow  [0.27]  COLGATEPALMO  2899.9 ATS - Market Arrow  [1.41]  DABUR INDIA  562.65 ATS - Market Arrow  [5.99]  DLF  870.45 ATS - Market Arrow  [-1.87]  DRREDDYSLAB  6278.25 ATS - Market Arrow  [-0.36]  GAIL  194.75 ATS - Market Arrow  [-1.49]  GRASIM INDS  2436.8 ATS - Market Arrow  [-0.64]  HCLTECHNOLOG  1330.1 ATS - Market Arrow  [-2.18]  HDFC  2729.95 ATS - Market Arrow  [-0.62]  HDFC BANK  1511 ATS - Market Arrow  [-0.77]  HEROMOTOCORP  4504.05 ATS - Market Arrow  [-0.12]  HIND.UNILEV  2357.1 ATS - Market Arrow  [4.51]  HINDALCO  632.55 ATS - Market Arrow  [-0.93]  ICICI BANK  1131.1 ATS - Market Arrow  [-1.54]  IDFC  115.65 ATS - Market Arrow  [-2.07]  INDIANHOTELS  573.7 ATS - Market Arrow  [0.48]  INDUSINDBANK  1475.55 ATS - Market Arrow  [-1.52]  INFOSYS  1418.45 ATS - Market Arrow  [-0.52]  ITC LTD  443.8 ATS - Market Arrow  [2.12]  JINDALSTLPOW  926.65 ATS - Market Arrow  [-1.06]  KOTAK BANK  1625.95 ATS - Market Arrow  [0.07]  L&T  3465 ATS - Market Arrow  [0.08]  LUPIN  1634.4 ATS - Market Arrow  [-2.70]  MAH&MAH  2200 ATS - Market Arrow  [-1.11]  MARUTI SUZUK  12313.55 ATS - Market Arrow  [-0.96]  MTNL  36.35 ATS - Market Arrow  [-0.74]  NESTLE  2520 ATS - Market Arrow  [2.52]  NIIT  102.75 ATS - Market Arrow  [-0.58]  NMDC  265.25 ATS - Market Arrow  [-1.49]  NTPC  351.25 ATS - Market Arrow  [-1.51]  ONGC  279.45 ATS - Market Arrow  [-0.90]  PNB  124.8 ATS - Market Arrow  [-1.81]  POWER GRID  299.25 ATS - Market Arrow  [-2.49]  RIL  2805.55 ATS - Market Arrow  [-1.18]  SBI  803.1 ATS - Market Arrow  [-0.58]  SESA GOA  405.65 ATS - Market Arrow  [-1.21]  SHIPPINGCORP  213.15 ATS - Market Arrow  [-1.02]  SUNPHRMINDS  1528.75 ATS - Market Arrow  [-0.06]  TATA CHEM  1069.9 ATS - Market Arrow  [-1.20]  TATA GLOBAL  1107.6 ATS - Market Arrow  [0.85]  TATA MOTORS  1008.8 ATS - Market Arrow  [-0.69]  TATA STEEL  166 ATS - Market Arrow  [-0.95]  TATAPOWERCOM  439.6 ATS - Market Arrow  [-1.47]  TCS  3924.9 ATS - Market Arrow  [0.11]  TECH MAHINDR  1259.65 ATS - Market Arrow  [-0.21]  ULTRATECHCEM  9654 ATS - Market Arrow  [-1.27]  UNITED SPIRI  1219.3 ATS - Market Arrow  [-0.86]  WIPRO  455.15 ATS - Market Arrow  [-0.68]  ZEETELEFILMS  135.65 ATS - Market Arrow  [-0.73]  

Thyrocare Technologies Ltd.

Notes to Accounts

NSE: THYROCAREEQ BSE: 539871ISIN: INE594H01019INDUSTRY: Hospitals & Medical Services

BSE   Rs 612.05   Open: 620.45   Today's Range 611.10
620.45
 
NSE
Rs 612.05
-9.05 ( -1.48 %)
-8.75 ( -1.43 %) Prev Close: 620.80 52 Week Range 449.95
722.00
You can view the entire text of Notes to accounts of the company for the latest year
Market Cap. (Rs.) 3240.97 Cr. P/BV 6.12 Book Value (Rs.) 100.05
52 Week High/Low (Rs.) 723/448 FV/ML 10/1 P/E(X) 50.36
Bookclosure 20/04/2023 EPS (Rs.) 12.15 Div Yield (%) 2.94
Year End :2022-03 

Measurement of fair values

- The Company has sub-let part of the leasehold land and constructed building thereon, to its subsidiary for business operations after getting an approval from the lessor. Since the premises is constructed on leasehold plot of land, the sub-let part of the premises is not saleable independently. The fair value of the investment property would be difficult to determine reliably. The premises is constructed on industrial leasehold plot of land and there are very few recent transactions. In case of the previously observed transaction for transfer of plot prices, the variations in the prices indicate that the transfer price is not indicative of market prices. Also, the alternative reliable measurement of fair value are not available due to the regulatory restrictions as to usage, transfer, leasing and subletting of the property within the jurisdiction. The fair value of the investment property on the basis of then observed transfer prices for the properties within the same jurisdiction, ranges from INR 2.55 crore to 3.00 crore.

Rights, preferences and restrictions attached to equity shares

The Company has a single class of equity shares. Accordingly all equity shares rank equally with regard to dividends and share in the Company’s residual assets on winding up. The equity shareholders are entitled to receive dividend as declared from time to time. The voting rights of an equity shareholder on a poll (not on show of hands) are in proportion to his/ its share of the paid-up equity share capital of the Company.

On winding up of the Company, the holders of equity shares will be entitled to receive the residual assets of the Company, remaining after distribution of all preferential amounts, in proportion to the number of equity shares held.

Employee stock option plan

Terms attached to stock options plan to employees are described in Note 33 regarding share-based payments.

Equity shares bought back

During the year ended 31 March 2019, the Company bought back 9,58,900 equity shares for an aggregate amount of ' 63.00 crore being 1.78% of the total paid up equity share capital, at an average price of ' 656.90 per equity share. The equity shares bought back were extinguished on 12 October 2018 and 22 October 2018.

Capital reserve

Capital Reserve represents a) amounts received in earlier years from the selling shareholder at the time of the IPO towards reimbursement of certain expenses and b) fair of the trademark "Whaters” (subsequently disposed off) assigned by Dr A Velumani in favour of the Company for no consideration.

Securities premium

Securities premium represents the premium received on issue of shares. It is utilized in accordance with the provisions of the Companies Act, 2013.

Share option outstanding account

The Company has established various equity-settled share-based payment plans for certain categories of employees of the Company. The balance in the share option outstanding account represents the expenses recorded pursuant to the aforesaid schemes for which the options are not yet vested or exercised. (See Note 33 for further details on these plans).

General reserve

General reserve is used to record the transfer from retained earnings of the Company. It is utilized in accordance with the provisions of the Companies Act, 2013.

Capital redemption reserve

The Company bought back 9,58,900 equity shares for an aggregate amount of Rs. 63.00 crore being 1.78% of the total paid up equity share capital, at an average price of Rs. 656.90 per equity share. The equity shares bought back were extinguished on 12 October 2018 and 22 October 2018 and as per the provisions of the Companies Act, 2013, the Capital redemption reserve is used to record the reduction of the share capital of the Company on account of equity shares bought back out of the accumulated profits. It is created in accordance with the provisions of the Companies Act, 2013.”

32. Employee benefits

A. Defined contribution plans

The Company makes Provident Fund, ESIC and Maharashtra Labour Welfare Fund contributions to defined contribution plans for qualifying employees. Under the Schemes, the Company is required to contribute a specified percentage of the payroll costs to fund the benefits. The Company recognised ' 3.32 crore for the year ended 31 March 2022 (31 March 2021 : ' 2.92 Crore) for Provident Fund contributions, ' 0.72 crore (31 March 2021 : ' 0.65 Crore) for ESIC contributions and Rs. 0.01 crore (31 March 2021 : ' 0.01 Crore) for Maharashtra Labour Welfare Fund, in the Statement of Profit and Loss during the year (See note 28). The contributions payable to these plans by the Company are at rates specified in the rules of the schemes. The Company does not expect any further liability other than the specified contributions.

B. Defined benefit plans

The Company offers the following employee benefit schemes to its employees :

The sensitivity analysis have been determined based on reasonably possible changes of the respective assumptions occurring at the end of the reporting period, while holding all other assumptions constant. The sensitivity analysis presented above may not be representative of the actual change in the projected benefit obligation as it is unlikely that the change in assumptions would occur in isolation of one another as some of the assumptions may be correlated. Furthermore, in presenting the above sensitivity analysis, the present value of the projected benefit obligation has been calculated using the projected unit credit method at the end of the reporting period, which is the same method as applied in calculating the projected benefit obligation as recognised in the balance sheet.

There was no change in the methods and assumptions used in preparing the sensitivity analysis from prior years.

33. Share-based payments

A. Description of share-based payment arrangements

During the year, the Company has offered stock options to the eligible employees under "THYROCARE EMPLOYEES STOCK OPTION SCHEME 2021” (ESOS2021) vide authorisation of shareholders in the annual general meeting held on 26 June 2021. The options may be exercised either fully or partially in four equal instalments. The employees were identified as those who had completed two years of service as on the date of sanction of the scheme, subject to their continuous service till the vesting period.

During the earlier years, the Company had offered stock options to the eligible employees under "THYROCARE EMPLOYEES STOCK OPTION SCHEME 2020” (ESOS2020), "THYROCARE EMPLOYEES STOCK OPTION SCHEME 2019” (ESOS2019), "THYROCARE EMPLOYEES STOCK OPTION SCHEME 2018” (ESOS2018), "THYROCARE EMPLOYEES STOCK OPTION SCHEME 2017” (ESOS2017), "THYROCARE EMPLOYEES STOCK OPTION SCHEME 2016” (ESOS2016) and "THYROCARE EMPLOYEES STOCK OPTION SCHEME 2015” (ESOS2015) vide authorisation of shareholders in their meetings held on 29 September 2020, 24 August 2019, 1 September 2018, 12 August 2017, 12 September 2016 and 26 September 2015 respectively. Under the respective scheme, the options may be exercised either fully or partially in four equal instalments. The employees were identified as those who had completed certain years of service subject to their continuous service till the vesting period.

Additionally, the Company formed a trust, 'Thyrocare Employee Stock Option Trust' wherein the shares to be issued under these options were allotted to the Trust. The Trust holds these shares for the benefit of the employees and issues them to the eligible employees as per the recommendation of the compensation committee. The identified employees are also entitled to purchase additional shares proportionately from the shares of employees who are not desirous to purchase the equity shares or who have left the organisation.

B. Measurement of fair values

The Management assessed that cash and bank balances, trade receivables, trade payables and other financial assets and liabilities approximate their carrying amounts largely due to short-term maturities of these instruments.

The fair value of investment in mutual funds is included at the amount at which the instruments could be exchanged in a current transaction between willing parties, other than in a forced or liquidation sale. The following methods and assumptions were used to estimate the fair values: - The fair value of the quoted investments/units of mutual fund scheme are based on net asset value at the reporting date as published by the mutual fund.

The following table provides the fair value measurement hierarchy of the Company’s financial instruments which are measured at fair value:

 
STOCKS A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z|Others

Mutual Fund A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others

SEBI Registration No's: NSE / BSE / MCX : INZ000166638. Depository Participant: IN- DP-224-2016.
Compliance Officer :- Name: Ch.V.A. Varaprasad, Mobile No.: 9393136201, E-mail: varaprasad.challa@rlpsec.com
Grievance Cell: rlpsec_grievancecell@yahoo.com , rlpdp_grievancecell@yahoo.com
Procedure to file a complaint on SEBI SCORES: Register on SCORES portal. Mandatory details for filing complaints on SCORES: Name, PAN, Address, Mobile Number, E-mail ID. Benefits: Effective Communication, Speedy redressal of the grievances.
Copyrights @ 2014 © RLP Securities. All Right Reserved Designed, developed and content provided by